GC
GatePass Capital Portfolio holdings
AUM
$173M
1-Year Est. Return
35.34%
1 Year Est. Return
+35.34%
AUM
$151M
AUM Growth
+$17.3M
(+13%)
Holding
131
Top Buys
| 1 | +$2.98M | |
| 2 | +$1.03M | |
| 3 | +$936K | |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$848K |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$659K |
Top Sells
| 1 | +$1.84M | |
| 2 | +$1.01M | |
| 3 | +$469K | |
| 4 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$441K |
| 5 |
Pfizer
PFE
|
+$409K |
Sector Composition
| 1 | Financials | 18.65% |
| 2 | Consumer Discretionary | 5.74% |
| 3 | Technology | 5.27% |
| 4 | Industrials | 3.33% |
| 5 | Consumer Staples | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
GoodRx Holdings
GDRX
$913M
| $49.8K | 0.03% |
10,000
|
|
||
127
Vanguard Short-Term Bond ETF
BSV
$42.5B
| – | – |
-3,339
|
|
||
128
INmune Bio
INMB
$40.7M
| – | – |
-235,000
|
|
||
129
iShares Russell 2000 ETF
IWM
$77.6B
| – | – |
-2,042
|
|
||
130
UnitedHealth
UNH
$302B
| – | – |
-422
|
|
||
|
EQC
131
DELISTED
Equity Commonwealth
EQC
| – | – |
-69,260
|
|